Herpes simplex virus

From IDWiki
Revision as of 17:24, 16 October 2019 by Aidan (talk | contribs) (: filled out many more presentations)
  • Comprises herpes simplex virus 1 (HSV-1) and HSV-2, which are members of the Human herpesvirus family
  • Cause typical painful vesicular lesions on labia or external genitals
  • Occasionally cause a viral encephalitis

Background

Microbiology

  • Enveloped, double-stranded DNA virus
  • HSV-1 and HSV-2 are morphologically and genetically distinct viruses
  • Can be infected with both

Epidemiology

  • Worldwide distribution, and only found in humans
  • Most common cause of genital lesions
  • Spread through person-to-person contact with skin or mucosa; not spread via fomits
  • HSV-1 is more common, with 90% of adults having antibodies by age 40
    • Often acquired in childhood in Asia and Africa
    • More common in lower SES populations
  • HSV-2 has seroprevalence of 15-20% in US
    • More common in women than men, in HIV-infected people, and in MSM
    • May be subclinical if already infected with HSV-1

Pathophysiology

  • Fusion of envelope and cell membrane is mediated by viral glycoproteins B, C, and D and host cell proteins cellular heparin sulfate, TNF receptors, and immunoglobulins
  • Internal capsid is released, which makes its way to the nucleus
  • Viral DNA polymerase enzyme and viral DNA helicase are targets of antivirals
  • Viral DNA may remain latent in about 10% of nearby neurons, characterized by latency-associated transcripts (LATs)
    • Despite being latent, virus can still be shed in mucosa anywhere from 1/10 to 3/4 of days
  • HSV-1 prefers trigeminal ganglia as well as cervical ganglia, or sacral nerve root ganglia if genital

Clinical Presentation

Primary infection

  • Incubation period usually within 5 days for primary infection
  • Mucocutaneous lesiosn may become secondarily infected

Orofacial infection

  • Most common sites of primary infection are gingivostomatitis and pharyngitis
    • Includes lesions on hard and soft palate, gingiva, tongue, lips, and face
    • Pharyngeal lesions may be exudative or ulcerative
  • May also have malaise, myalgias, anorexia or odynophagia, and cervical lymphadenopathy
  • Self-resolving after 3 to 14 days
  • Can cause a Bell palsy

Genital infection

  • Genital lesions typically last 10 to 12 days, especially with first episode
    • Often widely spaced bilateral lesions
    • First episode often also involves fever, headache, malaise, and myalgias
    • May have pain, itching, dysuria, genital discharge, and inguinal lymphadenopathy
  • May develop extragenital sites of infection, including buttock, groin, and thigh with HSV-2 and perioral area with HSV-1
    • Rarely fingers and eyes
    • Develop around 14 days into the disease, likely from autoinoculation
  • HSV-2 genital infections are less severe if the person has had HSV-1
  • 12-month recurrence rate is up to 90% for HSV-2 and 55% for HSV-1
Neurological complications
  • These can include aseptic meningitis, transverse myelitis, and sacral radiculopathy
  • Typically occur in conjunction with first episode of genital HSV-2 infection
  • Aseptic meningitis
    • Mengitis is more common with HSV-2 than HSV-1
    • Often concurrent with primary genital infection, typically 3 to 12 days after start of symptoms
    • HSV-2 may also cause Mollaret's meningitis (benign recurrent lymphocytic meningitis)
  • Autonomic dysfunction
    • May have hyperesthesia or anaesthesia of perineum, lumbar or sacrum, as well as urinary retention and constipation
    • Resolves over 4 to 8 weeks
  • Transverse myelitis
    • Decreased strength and deep tendon reflexes in lower extremities in conjunction with autonomic dysfunction (as above)
Pelvic inflammatory disease
  • Rare cause of PID, possibly representing dual infection with a typical bacterial copathogen
Disseminated disease
  • Rarely can disseminate
  • Can be cutaneous, with concurrent meningitis, hepatitis, and pneumonitis
  • Can also involve monocular arthritis, thrombocytopenia, adrenal necrosis, and myoglobinuria
  • Patient factors include primary genital HSV in pregnancy, reactivation of genital HSV in a patient with cellular immunocompromise

Reactivation

  • Typically localized to a single mucocutaneous area
  • Symptoms are usually more minor than first-episode or primary infection, and include itching and pain
    • Lesions may be atypical, with fissures and unusual ulcers
    • May be subclinical, with intermittent viral shedding
    • May be preceded by a prodrome of tingling up to 2 days
  • Average duration of an episode of reactivation orolabial herpes is 5 days
  • HSV-1 reactivates more frequently around mouth, and HSV-2 in genitals
  • Frequency
    • HSV-2 reactivates on average 4 to 5 times annually, with a gradual decrease over time

Herpetic whitlow

  • HSV infection of the finger, with acute onset swelling, pain, and tenderness with vesicles
  • Also fever and regional lymphadenopathy
  • Can be either acquired from parson-to-person exposure or through autoinoculation
  • Higher rates in healtcare settins

Herpes gladiatorum

  • Herpes simplex infection essentially anywhere on the body (chest, ears, face, and hands) associated with wrestling

Ocular herpes

  • Keratitis, which presents with pain, blurred vision, chemosis, conjunctivitis, and corneal lesions
  • May also cause blepharitis and conjunctivitis
  • May cause chorioretinitis in infants and immunocompromised
  • Acute necrotizing retinitis
    • Presents with painless vision loss in immunocompetent people as well as immunocompromised
    • 25% of cases are bilateral

Encephalitis

Diagnosis

Management

References

  1. a b  M. Howard, J. W. Sellors, D. Jang, N. J. Robinson, M. Fearon, J. Kaczorowski, M. Chernesky. Regional Distribution of Antibodies to Herpes Simplex Virus Type 1 (HSV-1) and HSV-2 in Men and Women in Ontario, Canada. Journal of Clinical Microbiology. 2003;41(1):84-89. doi:10.1128/jcm.41.1.84-89.2003.